Jump to main content
Jump to site search

Issue 21, 2013
Previous Article Next Article

A smart T1-weighted MRI contrast agent for uranyl cations based on a DNAzyme–gadolinium conjugate

Author affiliations

Abstract

Rational design of smart MRI contrast agents with high specificity for metal ions remains a challenge. Here, we report a general strategy for the design of smart MRI contrast agents for detecting metal ions based on conjugation of a DNAzyme with a gadolinium complex. The 39E DNAzyme, which has high selectivity for UO22+, was conjugated to Gd(III)–DOTA and streptavidin. The binding of UO22+ to its 39E DNAzyme resulted in the dissociation of Gd(III)–DOTA from the large streptavidin, leading to a decrease of the T1 correlation time, and a change in the MRI signal.

Graphical abstract: A smart T1-weighted MRI contrast agent for uranyl cations based on a DNAzyme–gadolinium conjugate

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Jun 2013, accepted on 10 Aug 2013 and first published on 12 Aug 2013


Article type: Communication
DOI: 10.1039/C3AN01182H
Citation: Analyst, 2013,138, 6266-6269
  •   Request permissions

    A smart T1-weighted MRI contrast agent for uranyl cations based on a DNAzyme–gadolinium conjugate

    W. Xu, H. Xing and Y. Lu, Analyst, 2013, 138, 6266
    DOI: 10.1039/C3AN01182H

Search articles by author

Spotlight

Advertisements